MME
WST icon

Meag Munich Ergo’s West Pharmaceutical WST Stock Holding History

Meag Munich Ergo’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-190
Closed -$71.3K – 194
2023
Q3 		$71.3K Buy
+190
New +$73.5K ﹤0.01% 177
2022
Q2 		– Sell
-1,234
Closed -$513K – 235
2022
Q1 		$513K Sell
1,234
-1,194
-49% -$467K 0.04% 167
2021
Q4 		$1.15M Buy
+2,428
New +$1.05M 0.08% 110
2021
Q3 		– Sell
-2,046
Closed -$735K – 324
2021
Q2 		$735K Sell
2,046
-73
-3% -$24.1K 0.07% 221
2021
Q1 		$597K Buy
+2,119
New +$606K 0.06% 232

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Meag Munich Ergo's WST Position: Q4 2023 in Review

Meag Munich Ergo sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 190 shares — an estimated $71.3K sold.

Meag Munich Ergo first reported a position in WST in Q1 2021 and held it in 5 quarters. The position peaked at $1.15M in Q4 2021. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Meag Munich Ergo reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Meag Munich Ergo sold 190 West Pharmaceutical shares in Q4 2023, an estimated $71.3K.
  • Meag Munich Ergo first reported a position in West Pharmaceutical in Q1 2021 and held it in 5 quarters.
  • Meag Munich Ergo's West Pharmaceutical position peaked at $1.15M in Q4 2021.
  • 783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Meag Munich Ergo's 13F filing for Q4 2023, filed 19 Jan 2024.